(1)
Jungić, S. M.; Tubić, B.; Gajanin, R.; Gojković, Z.; Rakita, I. Efficacy and safety of bevacizumab in combination with irinotecan and capecitabine in first-line treatment of metastatic colorectal cancer. Vojnosanit Pregl 2017, 74 (3), 249-255. https://doi.org/10.2298/VSP150513173J.